In a feasibility study of 
Introduction
The need for medical audit to assess and improve the quality of medical care is widely acknowledged.1-4 Although quality assessments of child health care have been undertaken in the United States, information is lacking for Britain. [5] [6] [7] Chemotherapy is a common form of management for childhood illness; 600' of children under 14 years of age receive at least one prescription a year from their general practitioners. 8 There have been few attempts, however, to assess the quality of prescribing for children. Two descriptive studies in Britain9 1 provided baseline data on the frequency of the broad groups of drugs prescribed for children and showed that the performance of a few doctors may have a considerable effect on certain prescribing rates.
Monitoring the quality of prescribing may focus either on the prescription of a specific drug-for instance, was tetracycline given appropriately for the illness and the patient ?-or the occurrence of a specific illness in a given patient group-for instance, for otitis media in infants was an appropriate drug regimen given ? The first method is the more attractive because prescription events are recorded on FP10 prescription forms.
Furthermore, in childhood, because certain drugs and drug combinations are contraindicated for certain age groups, inappropriate prescriptions may be identified in the absence of information concerning the illness. The British National Formulary states, for example, that "aspirin is not recommended for infants under 1 year because of the danger of metabolic disturbance. Fatal poisoning may occur with repeated doses."" Such a prescription in general practice may be presumed to reflect inappropriate care.
This paper describes a feasibility study which sought to determine the utility and validity of a method of assessing the quality of general practitioner prescribing for children. The study was part of a larger research project7 that examined and evaluated methods of assessing the quality of medical care for children using the tracer technique described and tested in the USA by Kessner.1" 13
Methods

MATERIALS
With the approval and help of the local medical committee, the local pharmaceutical committee, DHSS Branch PIE, and the Prescription Pricing Authority, 6331 original FP10 prescription forms for children who were exempt from prescription charges because they were under 16 years of age were obtained from the Prescription Pricing Authority at Newcastle. These forms represented the prescriptions for the month of September 1978 of a random sample of 72 general practitioners divided equally between two health districts in Wessex out of a work force of 277. Forms issued by locum doctors were not considered. Consent for the study was given on the understanding that anonymity and confidentiality would be assured. Inappropriate drug prescriptions, which should be avoided within certain age groups of children, were categorised into those that were "hazardous" (potentially life-threatening) and "undesirable." The latter group also comprised obsolete drugs and those of dubious medical efficacy. A list of supporting references for the following quality criteria is available on request.
Hazardous drugs according to age groups in years: aspirin <1, barbituarates other than phenobarbitone < 16, chloramphenicol < 16, diphenoxylate (Lomotil) <2, loperamide (Imodium) <4, antiemetic phenothiazines (prochlorperazine, trifluoperazine, perphenazine) < 1.
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Undesirable drugs according to age groups in years: tetracyclines < 11, tricyclic antidepressants <5, topical antihistamines < 16, diphenoxylate (Lomotil) 2-4, metoclopramide < 1, antiemetic phenothiazines (prochlorperazine, trifluoperazine, perphenazine) 1-4.
Other undesirable drugs were antidiarrhoeals (as in MIMS (14) section IE) < 1, the combination of any two antidiarrhoeals < where a specific record of age was essential for assessing quality of prescribing, 460% had no age recorded. Nine doctors (130') were found to have prescribed at least one hazardous drug during the month. Twenty-five (350 0) had prescribed at least one undesirable drug, four of whom had also prescribed a hazardous drug. Altogether 30 doctors (420/o) had prescribed at least one hazardous or one undesirable drug during the month. Ancillary staff had written 10"' of the forms containing hazardous or undesirable drugs; thus they had not written proportionately more inappropriate prescriptions than the doctors.
Some examples of inappropriate prescriptions were as follows. A 2-year-old child was prescribed imipramine (Tofranil) syrup 10 ml at night (200 ml), anda 10-month-old infant was given prochlorperazine (Stemetil) elixir 5 ml thrice daily (200 ml). A 3-month-old baby was given diphenoxylate (Lomotil) syrup 2 5 ml daily (50 ml) with kaolin (paediatric) 5 ml thrice daily (100 ml), with promethazine (Phergan) elixir 5 ml daily (100 ml). Compared with 204 prescriptions for antidiarrhoeals on the 6331 forms inspected, there was only one order for a dextrose-saline preparation.
Discussion
Quality is a relative term and like beauty is in the eye of the beholder. My advisers representing hospital as well as general practice considered the findings both reassuring and constructive since clear areas for improvements in practice were discovered. The major result of the feasibility study, however, was that levels of performance could be monitored conveniently and easily, subject to the necessary approvals and help. The recording on the part of ancillaries is not likely to be conducive to good practice. It was therefore worrying to find that ancillaries were considerably less likely to record the age of children than were the doctors. Most of the hazardous and undesirable drugs prescribed by 420' of the sample doctors have only been considered as such within the past decade. This raises the question whether standards of recommended practice are being passed to general practitioners in a speedy and effective manner. For example, the Drug and Therapeutics Bulletin1 6 discussed in detail the management of childhood diarrhoea nine months before the prescriptions were issued and yet 10%o of the sample doctors had prescribed drugs for children that were specifically cited as hazardous. This information, however, was distributed to only one-third of general practitioners in England-those that were newly qualified. The inappropriate use of some drugs, for instance, diphenoxylate, was confined to certain areas. Such prescribing does not appear to have stemmed from the region's teaching hospital (C F George, unpublished information) and may reflect the intensity of promotion activities of pharmaceutical companies.
From this study it would be unjustifiable to draw wider conclusions about a doctor who may be a high quality prescriber but who has had a single blind spot detected. For example, it is not known whether all doctors who prescribe one drug inappropriately also prescribe others inappropriately. Further work is required to establish to what extent quality of prescribing represents general quality of care. If it can be shown that there is a close relation prescribing would be an attractive indicator of quality since several diverse medical conditions can be studied conveniently by this approach.
The American experience mnakes it clear that there are no problem-free methods of evaluating the quality of health services. This study adopted the explicit (rigid) approach, which has been criticised since it might dictate complicated and exhaustive rule books. The alterative method of peer review, bowever, is unsuitable to gauge the level of care on a wide basis, particularly when several services are attempting to achieve similar goals, as is the case in child health care. Providing the explicit approach is restricted to assessment of the "practice" rather than the "practitioner", individual doctors should not be threatened. Both approaches should be complementary. Having determined the degree and type of general problem, peer review at local level should then elicit causes and, if appropriate, administer remedies.
Is it true that the signs of hyponatraemia occur only when the total body sodium content is reduced, or may these be seen in dilutional hyponatraemia ?
The clinical features of hyponatraemia due to sodium depletion include muscle cramps, lethargy, loss of tissue turgor, sunken orbits, and postural and eventually sustained hypotension; the packed cell volume and plasma protein concentrations are raised if not affected by the primary disease. None of these features is encountered in dilutional hyponatraemia (defined as due to increased body water with a normal body sodium content). Two classic causes of this condition are inappropriate secretion of antidiuretic hormone due to carcinoma of the bronchus and acute renal failure. In carcinoma of the bronchus there are often no symptoms until the plasma sodium concentration falls below about 120 mmol (mEq)/l when mental confusion occurs. In acute renal failure the features are those of the primary disease and uraemia, but occasionally the same mental confusion is attributable to hyponatraemia and is relieved by correcting the plasma sodium concentration alone.' Are preparations containing 0-20 chlorhexidine gluconate safe to apply to nipples of women both antenatally and postnatally ?
The toxicity of hexachlorophane has no implications for the safety of chlorhexidine because they are entirely unrelated compounds.
All the available evidence suggests that application of preparations containing 0 2% of chlorhexidine gluconate is safe even on cracked nipples, and that they represent no serious risk to mother or baby. Chlorhexidine preparations are widely used for surgical skin preparation, and reports of skin sensitivity are extremely rare. Reports of adverse effects on the oral epithelium are few, and their significance is doubtful in the face of trials with chlorhexidine gels for treating recurrent aphthous ulcers in which no such adverse effects were found.' 2 Absorption of chlorhexidine administered by mouth is poor and toxicity low, as is suggested by the results of acute and chronic toxicity tests in animals; there is no evidence of risk of methaemoglobinaemia. Parachloroanaline, a postulated metabolite, has not been detected, but long storage at high temperature or heat sterilisation can lead to its formation, but even then all the evidence suggests that little risk results.3 Chlorhexidine, as indeed are many antiseptics, is incompatible with soaps but only at high concentration. It retains its effect at low concentrations of soap as, for example, those that remain on skin after normal washing. Chlorhexidine does not stain fabrics unless these are subsequently exposed to substances releasing free chlorine, such as hypochlorites. In summary, the inquirer's fears seem unfounded. 
